PCNA and neoplasm: Furthermore, administration of epimedokoreanin B significantly decreased both pSTAT3-positive area and PCNA-positive cells in subcutaneous tumor tissues (Figure 7C), thus indicating that epimedokoreanin B suppresses tumor development in a mouse model by inhibiting STAT3 activation in both macrophages and tumor cells.